Hemgenix has long been provided ‘conditional authorisation’. This means that the ecu Medicines Agency made a decision that the key benefits of Hemgenix are better than its risks, but the company must supply extra evidence after authorisation.a panel of three of clinical experts with skills in diagnosing and treating people with hemophilia BIndi